iZafe Group AB (publ) (STO:IZAFE.B)
Sweden · Delayed Price · Currency is SEK 0.3130
-0.0220 (-6.57%)
At close: May 20, 2026
iZafe Group AB Company Description
iZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home.
The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time.
It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally.
The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019.
iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
iZafe Group AB (publ)
| Country | Sweden |
| Founded | 2008 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Anders Segerstrom |
Contact Details
Address: David Bagares Gata 3 Stockholm Sweden | |
| Phone | 46 8 21 11 21 |
Stock Details
| Ticker Symbol | IZAFE.B |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0003656834 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Anders Segerstrom | Chief Executive Officer |
| Barbro Stahle Sjonell | Co-Founder |
| Marius Sandberg | Chief Financial Officer |
| Mikael Svensson | Chief Operating Officer |
| Erik Gillsbro | Chief Technology Officer |
| Helena Ronnqvist | CMO and BUM of Pilloxa |